Market research
HLS.AU Healius Limited
AU AUD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 312M
- P/E ratio
- Not available
- Analyst target
- 0.5474
- Dividend yield
- Not available
- Beta
- 0.29
Community
Investor discussion
1 comment
Sign in to join the HLS.AU discussion.
5 years, 5 months ago
Healius Limited is currently in a long term uptrend where the price is trading 18.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Healius Limited's total revenue rose by 0.8% to $952M since the same quarter in the previous year.
Its net income has dropped by 5.3% to $63M since the same quarter in the previous year.
Finally, its free cash flow grew by 2798.4% to $91M since the same quarter in the previous year.
Based on the above factors, Healius Limited gets an overall score of 4/5.